VHA

VA to cover Eisai's new Alzheimer's drug after declining to cover Aduhelm
Endpoints
Mon, 03/13/23 - 04:44 pm
VHA
Eisai
Biogen
Leqembi
Aduhelm
Alzheimer's disease